Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.
We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.
argenx is a global immunology company focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex targets, to treat diseases with significant unmet medical need. As we strive to achieve VISION 2030, our long-term commitment to transform the treatment of autoimmune diseases, innovation remains core to the argenx mission.
The use of Real-World Evidence (RWE) to support decision making by regulators, payors & health technology assessment (HTA) authorities, health care providers (HCPs), patient organizations, and other stakeholders has accelerated. In support of argenx marketed products or those in development, the Director, Real World Evidence (RWE) Scientist, will serve as the product/indication RWE Lead, collaborating with internal colleagues and external collaborators to develop and execute the RWE strategy. He/she will plan, design, execute and communicate findings from RWE studies that may be used to inform internal development and commercialization efforts and to support communication with external healthcare decision makers. For example, RWE objectives may include but not be limited to quantifying the burden of illness and the value of argenx’s innovative therapies to address that burden, providing data to inform clinical trial designs, supporting development and validation of Clinical Outcome Assessment measures, and generating data to address unanswered clinical questions.
As the product/indication RWE lead, he/she will work closely with cross-functional argenx teams, including colleagues from HEOR, Clinical Development, Medical Affairs, Market Access, Commercial, Patient Advocacy, Business Development, Legal, Global Patient Safety, and Regulatory to align on the strategy and tactics for evidence generation. This individual will lead or support scientifically credible retrospective and prospective RWE projects and oversee relevant budgets, timelines, and quality. The Director, Real World Evidence Scientist will report to the Head of Real World Evidence in the Medical Affairs & Evidence Generation organization.
At argenx, all applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics. argenx is proud to be an equal opportunity employer.
Before you submit your application, CV or any other personal details to us, please review our argenx Privacy Notice for Job Applicants to learn more about how argenx B.V. and its affiliates (“argenx”) will handle and protect your personal data. If you have any questions or you wish to exercise your privacy rights, please contact our Global Privacy Office by email at privacy@argenx.com.
If you require reasonable accommodation in completing your application, interviewing, or otherwise participating in the candidate selection process please contact us at hr.us@argenx.com. Only inquiries related to an accommodation request will receive a response.